First patent awarded to a micronutrient preparation for the support of endometriosis

Endometriosis: key symptom pain

Endometriosis is a chronic disease that affects about 10% of all women of childbearing age. In endometriosis, tissue strongly resembling uterine lining grows outside the inner uterine cavity. This tissue reacts to the female menstrual cycle like uterine mucosa itself, i.e. it builds up during the cycle, breaks down at the time of menstruation, but cannot leave the body. This leads to inflammation, which can be felt as intense pain (not only during menstruation). Unfortunately, diagnosis often is difficult and may take a long time. It is not uncommon that endometriosis is only diagnosed when a patient with an unfulfilled desire to have a child presents at a fertility clinic.

Common cause of subfertility

This is because endometriosis not only affects the well-being of women, but can also impair natural conception. For instance, when endometriomas are found in the area of the fallopian tubes, they may constitute a mechanical obstacle to a natural conception. Very often, endometriosis-associated inflammation and oxidative stress may impair healthy fertility by lowering oocyte quality.

Therapy options

Unfortunately, treatments for the disease are often quite invasive and include both surgical procedures and strong drugs. However, an influence of lifestyle and diet has also been established and many women are highly interested to use this knowledge to their advantage. In particular, stress-reduction, minding individual intolerances and an anti-inflammatory diet present helpful for many women.

First patent granted for orthomolecular treatment

Nevertheless, so far there has been nothing available for endometriosis patients in the otherwise comprehensive micronutrient market. This often made orthomolecular treatment unnecessarily complicated and expensive. It is all the more pleasing that the first patent has finally been granted for a product that supports endometriosis patients gently and naturally from within with the help of a specific nutrient combination (Fertilovit® F Endo). It is particularly interesting for women wishing to have children that, according to initial studies, the ingredients can also contribute to the protection of sensitive oocytes from damage caused by increased inflammation and oxidative stress due to endometriosis. The patent holder is Gonadosan Distribution GmbH, based in Bregenz, Austria. The product manager, Doctor Birgit Wogatzky, explains: "As a company, we originate from the field of fertility medicine and have specialized in supportive micronutrient therapy of fertility patients since our inception."
With the Fertilovit® product line (www.fertilovit.com), the company already offers a selection of special micronutrient preparations for fertility patients with a wide range of medical histories. However, since many patients who present with unfulfilled desire to have children suffer from endometriosis, it was a concern to finally be able to offer these patients targeted support as well.

Innovative combination product supports and protects

New research data enabled the development of the combination product Fertilovit® F Endo (https://shop.fertilovit.com/fertilovit-products/en-fertilovit-f-endo-45.aspx), which provides patients not only with the protective folic acid, which is important for women wishing to have children, but also with special antioxidants and anti-inflammatory nutrients. Study data show that in many cases this can be an extremely helpful and at the same time gentle support when planning for pregnancy. A pleasant side effect for many patients is that it is not uncommon to see an improvement in the pain situation. By the way, the patented combination is available both in pharmacies as well as on the Internet (https://shop.fertilovit.com/fertilovit-products/en-fertilovit-f-endo-45.aspx).

Gonadosan Distribution GmbH
Roemerstr. 2
6900 Bregenz
Austria
Tel. +43 5574 54195
Email: office@fertilovit.com
Web: www.fertilovit.com

Gonadosan - this is the name of an innovative company with branches in Switzerland and Austria.

An interdisciplinary team is continuously working on the development and research of new orthomolecular concepts. The know-how and extraordinary commitment of this team contribute significantly to the success of the company and its products.

This release was published on openPR.